TNI Medical AG, based in Wurzburg, Germany, sells High Flow Therapy devices for patients with respiratory insufficiency.
Founded in 2007 and headquartered in Wurzburg, Germany, TNI Medical AG develops therapies for respiratory insufficiency, centered on its High Flow Therapy, which delivers oxygen-enriched air through nasal insufflation. Its customers are hospitals, clinics, and medical suppliers, and it sells devices and consumables through negotiated contracts. The company raised EUR 3.00 mn led by Pathena on March 19, 2020, and was targeted for acquisition by Masimo Corporation, expected to close in Q2 2020. Ewald Anger is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in